DHR
Danaher Corporation
$197.57
▲ +1.33%
+$2.59
NYSE · Healthcare · Diagnostics & Research
· price updated 9h ago
Danaher Corporation
DHR · NYSE · Healthcare · Diagnostics & Research · price updated 9h ago
$197.57
▲ +1.33% · +$2.59 today
AI research · $197.57
DHR, researched
Sell-off overdone – analyst target 26% above current
refreshed Jul 24
price position
Where DHR sits now
52-week range
Low$160.93
High$242.80
Today $197.57
RSI (14)
51.4Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$4.3B
Total debt$26.6B
Net cash after debt$-22.2B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 21% above Sector avg
22.03x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
5.46x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
25.08x
EV / EBITDA
Operating value including debt
Reasonable · Between 12x and 22x EBITDA
20.97x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
6.4%
ROE
Profit generated from shareholder equity
Needs attention · Lagging most sector peers
7.6%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.53x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
1.65x
Business mix
Jun 30, 2026Diagnostics40.1% · $10.1B
Biotechnology30.1% · $7.5B
Life Sciences29.8% · $7.5B
Geographic mix
Jun 30, 2026North America58.0% · $10.3B
Western Europe34.9% · $6.2B
Other Developed Markets7.1% · $1.3B
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How DHR compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $137.07B | 34.6 | +4.6% | 56 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
activity
What is moving DHR
US stock research
About Danaher Corporation (DHR) stock
Danaher Corporation tracked in the US core universe. DHR was +1.3% in the latest available session at $197.57. Its reported market value was $137.07B with a trailing P/E of 34.6. Latest reported revenue was $25.11B, changing +4.6% year over year, with $4.00B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $197.57
- Day change
- +1.3%
- Market cap
- $137.07B
- P/E (TTM)
- 34.6
- Revenue growth
- +4.6%
- Industry
- Diagnostics & Research